Immunomic Therapeutics and TRIANNI Sign License Agreement for The Trianni Mouse™ by ITI in Featured, Highlights, Press Releases Immunomic Therapeutics and TRIANNI Sign License Agreement for The Trianni Mouse™ May 18, 2017 Eastern Standard Time ROCKVILLE, Md. & SAN FRANCISCO--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, ... Read More